Robert W. Simms
Boston University · 166 works · 21,539 citations · h-index 59
Top works
- 2013 Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative
- 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative
- Cyclophosphamide versus Placebo in Scleroderma Lung Disease
- Guidelines for monitoring drug therapy in rheumatoid arthritis. American College of Rheumatology Ad Hoc Committee on Clinical Guidelines.
- Treatment of 100 patients with primary amyloidosis: A randomized trial of melphalan, prednisone, and colchicine versus colchicine only
- Digital ulcers in systemic sclerosis: Prevention by treatment with bosentan, an oral endothelin receptor antagonist
- Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial
- Dose-intensive melphalan with blood stem cell support for the treatment of AL amyloidosis: one-year follow-up in five patients
- Guidelines for the Management of Rheumatoid Arthritis
- High frequency of fibromyalgia in patients with chronic fatigue seen in a primary care practice
- Effects of 1-Year Treatment with Cyclophosphamide on Outcomes at 2 Years in Scleroderma Lung Disease
- Recombinant Human Relaxin in the Treatment of Scleroderma
- Systemic sclerosis
- Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon
- Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma
- Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial
- Liver Transplantation as a Treatment for Familial Amyloidotic Polyneuropathy
- Improvement in the polyneuropathy associated with familial amyloid polyneuropathy after liver transplantation
- Autonomic neuropathy in AL (primary) amyloidosis and its effect on survival
- Tenderness in 75 anatomic sites. distinguishing fibromyalgia patients from controls